» Articles » PMID: 22897850

H2.0-like Homeobox Regulates Early Hematopoiesis and Promotes Acute Myeloid Leukemia

Overview
Journal Cancer Cell
Publisher Cell Press
Specialty Oncology
Date 2012 Aug 18
PMID 22897850
Citations 32
Authors
Affiliations
Soon will be listed here.
Abstract

Homeobox domain-containing transcription factors are important regulators of hematopoiesis. Here, we report that increased levels of nonclustered H2.0-like homeobox (HLX) lead to loss of functional hematopoietic stem cells and formation of aberrant progenitors with unlimited serial clonogenicity and blocked differentiation. Inhibition of HLX reduces proliferation and clonogenicity of leukemia cells, overcomes the differentiation block, and leads to prolonged survival. HLX regulates a transcriptional program, including PAK1 and BTG1, that controls cellular differentiation and proliferation. HLX is overexpressed in 87% of patients with acute myeloid leukemia (AML) and independently correlates with inferior overall survival (n = 601, p = 2.3 × 10(-6)). Our study identifies HLX as a key regulator in immature hematopoietic and leukemia cells and as a prognostic marker and therapeutic target in AML.

Citing Articles

Identification of hub genes and potential molecular mechanisms related to drug sensitivity in acute myeloid leukemia based on machine learning.

Zhang B, Liu H, Wu F, Ding Y, Wu J, Lu L Front Pharmacol. 2024; 15:1359832.

PMID: 38650628 PMC: 11033397. DOI: 10.3389/fphar.2024.1359832.


The predictive value of BTG1 for the response of newly diagnosed acute myeloid leukemia to decitabine.

Li Y, Mao X, Li M, Li L, Tong X, Huang L Clin Epigenetics. 2024; 16(1):16.

PMID: 38254153 PMC: 10802042. DOI: 10.1186/s13148-024-01627-9.


Blood-based DNA methylation in advanced Nasopharyngeal Carcinoma exhibited distinct CpG methylation signature.

Chatterjee K, Mal S, Ghosh M, Roy Chattopadhyay N, Roy S, Chakraborty K Sci Rep. 2023; 13(1):22086.

PMID: 38086861 PMC: 10716134. DOI: 10.1038/s41598-023-45001-w.


The Potential Dual Role of H2.0-like Homeobox in the Tumorgenesis and Development of Colorectal Cancer and Its Prognostic Value.

Chen S, Zhang L, Wang K, Huo J, Zhang S, Zhang X Can J Gastroenterol Hepatol. 2023; 2023:5521544.

PMID: 37719132 PMC: 10505080. DOI: 10.1155/2023/5521544.


Single-Cell RNA-seq Analysis of a Human Embryonic Stem Cell to Endothelial Cell System Based on Transcription Factor Overexpression.

Xu X, Chen J, Zhao H, Pi Y, Lin G, Hu L Stem Cell Rev Rep. 2023; 19(7):2497-2509.

PMID: 37537495 DOI: 10.1007/s12015-023-10598-y.


References
1.
Gentles A, Plevritis S, Majeti R, Alizadeh A . Association of a leukemic stem cell gene expression signature with clinical outcomes in acute myeloid leukemia. JAMA. 2010; 304(24):2706-15. PMC: 4089862. DOI: 10.1001/jama.2010.1862. View

2.
Kroon E, Krosl J, Thorsteinsdottir U, Baban S, Buchberg A, Sauvageau G . Hoxa9 transforms primary bone marrow cells through specific collaboration with Meis1a but not Pbx1b. EMBO J. 1998; 17(13):3714-25. PMC: 1170707. DOI: 10.1093/emboj/17.13.3714. View

3.
Edgar R, Domrachev M, Lash A . Gene Expression Omnibus: NCBI gene expression and hybridization array data repository. Nucleic Acids Res. 2001; 30(1):207-10. PMC: 99122. DOI: 10.1093/nar/30.1.207. View

4.
Tomasson M, Xiang Z, Walgren R, Zhao Y, Kasai Y, Miner T . Somatic mutations and germline sequence variants in the expressed tyrosine kinase genes of patients with de novo acute myeloid leukemia. Blood. 2008; 111(9):4797-808. PMC: 2343607. DOI: 10.1182/blood-2007-09-113027. View

5.
Fischbach N, Rozenfeld S, Shen W, Fong S, Chrobak D, Ginzinger D . HOXB6 overexpression in murine bone marrow immortalizes a myelomonocytic precursor in vitro and causes hematopoietic stem cell expansion and acute myeloid leukemia in vivo. Blood. 2004; 105(4):1456-66. DOI: 10.1182/blood-2004-04-1583. View